Hong Kong stocks are trending differently | Pharmaceutical stocks are on the rise again, domestic innovative drugs are expected to resonate with multiple positive factors, institutions say that data and BD catalysis are expected to become the main theme of the year.

According to the Securities Times app, pharmaceutical stocks are once again rising. As of the time of publication, China Antibody-B (03681.HK) is up 18.85% at 1.45 Hong Kong dollars; Yiming Oncology-B (01541.HK) is up 17.54% at 13.4 Hong Kong dollars; Zhao Yanxin Medicine (06127.HK) is up 14.96% at 14.6 Hong Kong dollars; Glori Pharmaceutical-B (01672) is up 12.25% at 7.97 Hong Kong dollars; and Hepalink Pharmaceutical-B (02142) is up 5.03% at 9.18 Hong Kong dollars.